Format

Send to

Choose Destination
Singapore Med J. 2017 Aug;58(8):473-480. doi: 10.11622/smedj.2017082.

Singapore Urological Association Clinical Guidelines for Male Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia.

Abstract

The first clinical guidelines for male lower urinary tract symptoms (LUTS)/benign prostatic hyperplasia (BPH) were published in 2005. An update is urgently needed in view of BPH being recognised as one of ten chronic illnesses by the Ministry of Health, Singapore. This review summarises the definition of BPH and the epidemiology of male LUTS/BPH in Singapore. BPH can be phenotyped with noninvasive transabdominal ultrasonography, according to intravesical prostatic protrusion and prostate volume, and classified according to severity (staging) for individualised treatment. At the initial evaluation, the majority of patients (59%) can be managed with fluid adjustment, exercise and diet; 32% with medications, using alpha blockers and/or 5-alpha reductase inhibitors for prostates weighing more than 30 g; and 9% with surgical intervention for more advanced disease. The 2015 guidelines comprise updated evidence that will help family medicine practitioners and specialists manage this common ailment more cost-effectively.

KEYWORDS:

benign prostatic hyperplasia; clinical guidelines; intravesical prostatic protrusion; male lower urinary tract symptoms; staging of clinical BPH

PMID:
28848988
PMCID:
PMC5563527
DOI:
10.11622/smedj.2017082
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Singapore Medical Association Icon for PubMed Central
Loading ...
Support Center